World Health Summit

[October 21-14, 2012]
Berlin, Germany

DNDi hosted a session entitled “Overcoming Regulatory Barriers to Meet Priority Health Needs in Developing Countries – Putting Theory into Practice”, and gave presentations in other sessions.
See the Online Programme
See DNDi at the World Health Summit Programme [PDF]

 

[October 23, 2012, 14:30-16:00]
Overcoming Regulatory Barriers to Meet Priority Health Needs in Developing Countries – Putting Theory into Practice 
DNDi – MMV

Chairs:

  • Nathalie Strub Wourgaft, Medical Director | Drugs for Neglected Diseases initiative (DNDi) | Switzerland
  • David Ubben, Director, Clinical Development | Medicines for Malaria Venture (MMV) | Switzerland

Speakers:

  • Regulatory Routes for Drugs in the Field of Neglected Diseases: Nathalie Strub Wourgaft, Medical Director | Drugs for Neglected Diseases initiative (DNDi) | Switzerland
  • Introducing Art. 58 – History, Experiences and Challenges:  Marie-Helene Pinheiro, Principal Regulatory Advisor | EMA | United Kingdom
  • Practical Experiences of Product Development Partnerships with Regulatory Procedures – Case Studies:  Carla Botting, Director, Product Development and Access | PATH Malaria Vaccine Initiative (MVI) | United States
  • Experiences of the Pharmaceutical Industry in the Field of Novel Neglected Disease Products:  Valérie Faillat-Proux, Regulatory Affairs Director,  Sanofi, France
  • The African Medicines Regulatory Harmonisation Initiative – Set Up And First Steps: Nditonda B. Chukilizo, Manager – Medicines and Cosmetics Evaluation and Registration | Tanzania Food and Drugs Authority (TFDA) | Tanzania,
  • Conclusions and Outlook: The Bigger Policy Framewor: David Ubben, Director, Clinical Development | Medicines for Malaria Venture (MMV) | Switzerland

More on this session

 

[October 22, 2012, 14:30-16:00]

Bringing Medicines to Low-Income Markets
Federal Ministry of Economic Cooperation and Development Sanofi


Chairs: 

  • Hans-Jürgen Beerfeltz,  Secretary of State,  Federal  Ministry  for Economic Cooperation and Development (BMZ),  Germany
  • Ibrahim Faisal, Deputy Vice Chancellor,  Upper Nile University, Khartoum, Sudan

Speakers:

  • Welcome Address: Hans-Jürgen Beerfeltz, Secretary of State | Federal Ministry for Economic Cooperation and Development (BMZ) | Germany
  • Partnership as Success Factor for Improving Global Health: Ibrahim Faisal, Deputy Vice Chancellor | Upper Nile University, Khartoum | Sudan
  • Moderation of Panel Discussion: Constanze Helmchen, Senior Manager | Deutsche Gesellschaft für internationale Zusammenarbeit (GIZ) | Germany
  • Introduction of the Study “Bringing Medicines to Low Income Markets”: Solveig Haupt,  Associated Expert | enterprise solutions for development (endeva) | Germany
  • Experience of NGOs: Nathalie Strub Wourgaft, Medical Director | Drugs for Neglected Diseases initiative (DNDi) | Switzerland
  • Enabling Inclusive Business through Development Politics:  Nicole Maldonado, Desk Officer, Division on Economic Policy; Financial Sector | Federal Ministry for Economic Cooperation and Development (BMZ) | Germany
  • Contribution of Health Industry to Global Health:  Robert Sebbag | Vice President Access to Medicines | Sanofi | France

More on this session

 

 

[October 22, 2012, 14:30-16:00]

Do We Need a Global Convention for R&D?
Policy Brief: Why as essential R&D Convention is needed
University of Heidelberg, McMaster University


Chairs:

  • Albrecht Jahn, University of Heidelberg | Germany
  • Steven J. Hoffman, McMaster University | Canada

Presentations:

  • John-Arne Rottingen, Visting Professor of Global Health and Population | Harvard University School of Public Health | United States
  • Odile Leroy, European Vaccine Initiative (EVI) | Germany
  • Carlos Corrrea, South Center | Switzerland
  • Petra Keil, Novartis | Germany
  • Bernard Pécoul, Executive Director | Drugs for Neglected Diseases initiative (DNDi) | Switzerland

More on this session

 

[October 23, 2012, 09:00-11:00]

Bringing Medicines to Low-Income Markets
Workshop
GIZ on behalf of Federal Ministry of Economic Cooperation and Development, Sanofi


Chairs:

  • Nathalie Strub Wourgaft, Medical Director | Drugs for Neglected Diseases initiative (DNDi) | Switzerland
  • Robert Sebbag,  Vice President Access to Medicines | Sanofi | France

Introductory Statements:

  • Solveig Haupt, Associated Expert | enterprise solutions for development (endeva) | Germany
  • Aline Krämer, Managing Director | Endeva UG | Germany
  • Nathalie Strub Wourgaft, Medical Director | Drugs for Neglected Diseases initiative (DNDi) | Switzerland
  • Robert Sebbag, Vice President Access to Medicines | Sanofi | France
  • Susan Seifert, Communications | Planet Finance Germany | Germany

More on this workshop